Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium
Antimicrobial-resistant Mycoplasma genitalium is becoming increasingly common and creating major treatment challenges. We present early data on combination therapy with doxycycline and sitafloxacin to treat highly resistant M. genitalium. We found the regimen was well tolerated and cured 11/12 infec...
Main Authors: | Duygu Durukan, Michelle Doyle, Gerald Murray, Kaveesha Bodiyabadu, Lenka Vodstrcil, Eric P.F. Chow, Jorgen S. Jensen, Christopher K. Fairley, Ivette Aguirre, Catriona S. Bradshaw |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2020-08-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/26/8/19-1806_article |
Similar Items
-
The rates of mutations associated with macrolide resistance in Mycoplasma genitalium among patients with non-gonococcal sexually transmitted infections in Smolensk and Tula
by: Zubareva L.M., et al.
Published: (2019-12-01) -
Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France
by: Chloé Le Roy, et al.
Published: (2016-09-01) -
Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem
by: Brian Arturo Mondeja, et al.
Published: (2018-11-01) -
Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017
by: Marta Adelantado, et al.
Published: (2019-11-01) -
Antimicrobial susceptibility of Mycoplasma genitalium isolates from Pretoria, South Africa in 2012 and 2016
by: Marie C. Le Roux, et al.
Published: (2018-06-01)